Skip to main content
Fig. 1 | Stem Cell Research & Therapy

Fig. 1

From: A novel conditioning regimen with pre-transplantation immunosuppression reduces the complication rates in hematopoietic stem cell transplantation in transfusion-dependent β-thalassemia

Fig. 1

Schematic diagram of the program consisting of multidrug pretransplant immune hematopoietic suppression therapy including courses of dexamethasone and fludarabine followed by a modified myeloablative conditioning regimen. The post-transplant GVHD prophylaxis consisted of CsA, MMF and short-term MTX. See Methods section for details

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512